LEVASOLE SOLUTION INJ 136.5MG/ML DIN 00733105
Health Canada record
| Active ingredient(s) | LEVAMISOLE PHOSPHATE 136.5 MG |
|---|---|
| Dosage form | Liquid |
| Route | Subcutaneous |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 31-Dec-1988 |
| Current status date | 04-Aug-2004 |
| Source | Health Canada DPD |
Establishment licence of the holder
Janssen Inc — licence 100239, currently licensed, last inspection rating C (2026-03-09).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing LEVAMISOLE PHOSPHATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00328804 | RIPERCOL L LEVAMISOLE PHOSPHATE INJ | CYANAMID CANADA INC. | Liquid | LEVAMISOLE PHOSPHATE 182 MG | Cancelled Post Market |